KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Arbutus Biopharma (ABUS) over the last 16 years, with Q3 2025 value amounting to 0.15.

  • Arbutus Biopharma's Asset Utilization Ratio rose 22390.49% to 0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15, marking a year-over-year increase of 22390.49%. This contributed to the annual value of 0.04 for FY2024, which is 5813.37% down from last year.
  • As of Q3 2025, Arbutus Biopharma's Asset Utilization Ratio stood at 0.15, which was up 22390.49% from 0.14 recorded in Q2 2025.
  • Over the past 5 years, Arbutus Biopharma's Asset Utilization Ratio peaked at 0.2 during Q4 2022, and registered a low of 0.04 during Q3 2024.
  • In the last 5 years, Arbutus Biopharma's Asset Utilization Ratio had a median value of 0.1 in 2022 and averaged 0.1.
  • In the last 5 years, Arbutus Biopharma's Asset Utilization Ratio skyrocketed by 22918.65% in 2022 and then crashed by 6615.78% in 2024.
  • Arbutus Biopharma's Asset Utilization Ratio (Quarter) stood at 0.06 in 2021, then skyrocketed by 229.19% to 0.2 in 2022, then plummeted by 38.75% to 0.12 in 2023, then tumbled by 62.12% to 0.05 in 2024, then surged by 220.5% to 0.15 in 2025.
  • Its Asset Utilization Ratio was 0.15 in Q3 2025, compared to 0.14 in Q2 2025 and 0.05 in Q1 2025.